Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

The grand opening of the new $10 million office complex will house its growing workforce in the Axis 25 Development at 4510 Byrd Drive near the Northern Colorado Regional Airport. As part of the expansion, the company also projects the creation of 85 new high-paying Loveland  jobs in the coming years in fields including science research, engineering, and project management. The company currently employs more than 140 full-time associates in Loveland.

“The relentless pursuit of innovation is what drives our business and our associates each and every day,” said Suzanne Foster, President of Beckman Coulter Life Sciences. “We continue to be impressed by the talent community that exists in greater Loveland, which has fueled our growth in Colorado since we came here in 2018 with nearly three-dozen associates. Our instruments are on the frontlines of major global research facilities, providing them with valuable automation solutions to accelerate answers for that next big breakthrough moment. We’re thrilled to be expanding in Loveland, where our growing team will play a key role in that evolution.”

The new state-of-the-art complex includes 56,000 square feet of office space featuring collaboration zones, breakout rooms, technology centers, gathering spaces, and a gym for associates.

The facility also includes a new innovative Customer Engagement Center which allows customers an inside look at the solutions available from Beckman Coulter Life Sciences, along with how they are created and can be tailored to meet individual and specialized laboratory needs.

The company also formally announces the initiation of its second phase of expansion in Loveland, with a 37,000-square-foot manufacturing operation to be attached to the office site. Ground is set to be broken by the second quarter of 2023, with an anticipated completion date in early 2024.

“I am excited to congratulate Beckman Coulter Life Sciences on their official opening today in Loveland, creating 85 good-paying jobs in Northern Colorado,” said Colorado Governor Jared Polis. “As Colorado continues to position itself as a leader in advanced industries like bioscience, I am thrilled to see more companies choosing to move and expand in our state.”

Beckman Coulter Life Sciences is also giving back to the greater Loveland community with a donation to Restoring Colorado’s Forests, which will ensure the planting of 140 trees – one for each current associate – to replace those lost due to the recent devastating wildfires and other environmental damage.

Beckman Coulter Life Sciences was assisted by CBRE, Etkin Johnson Real Estate Partners, and the Colorado Office of Economic Development and International Trade.

About Beckman Coulter Life Sciences

Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences.

Recent news from Beckman Coulter Life Sciences